| Literature DB >> 27980549 |
Maciej Polewczyk1, Wojciech Jacheć2, Aneta M Polewczyk3, Anna Polewczyk4, Marek Czajkowski5, Andrzej Kutarski6.
Abstract
INTRODUCTION: Spontaneous lead dislodgement into the pulmonary circulation is a rare complication of permanent pacing with unproven harmfulness and an indication of controversial class for transvenous lead extraction (TLE). AIM: To assess TLE safety in patients with leads dislodged into the pulmonary artery.Entities:
Keywords: intracardiac lead abrasion; lead dislodgement; transvenous lead extraction
Year: 2016 PMID: 27980549 PMCID: PMC5133324 DOI: 10.5114/aic.2016.63636
Source DB: PubMed Journal: Postepy Kardiol Interwencyjnej ISSN: 1734-9338 Impact factor: 1.426
Figure 1Broken lead dislocated into pulmonary artery (A), using a pigtail catheter the lead was retracted into the superior vena cava (B) and recaptured with a lasso (C)
LDPA patients’ characteristics
| Lead in pulmonary artery (LDPA) | Number | Percentage | |
|---|---|---|---|
| Lead part in PA | Proximal ending | 9 | 47.4 |
| Lead loops | 6 | 31.6 | |
| Distal ending (tip) | 4 | 21.1 | |
| Mechanism | Lead break/fracture | 10 | 52.6 |
| Lead ligature failure | 6 | 31.6 | |
| Lead dislodgement | 3 | 15.8 | |
| Location in PA | Pulmonary trunk | 7 | 36.8 |
| Right pulmonary artery | 8 | 42.1 | |
| Left pulmonary artery | 4 | 21.1 | |
| Lead destination | Right atrium | 4 | 21.1 |
| Right ventricle | 13 | 68.4 | |
| Cardiac vein | 2 | 10.5 | |
| Unit chest side | Left | 16 | 84.2 |
| Right | 3 | 15.8 | |
| Lead type | PM lead | 18 | 94.7 |
| ICD lead | 1 | 5.3 | |
| Lead polarity | BP | 13 | 68.4 |
| UP | 6 | 31.6 | |
| Extraction approach | Subclavian (femoral, auxiliary) | 18 | 94.7 |
| Femoral (only) | 1 | 5.3 | |
Demographic, cardiac implantable electronic device (CIED)-related parameters, the reason for TLE in groups depending on LDPA presence
| Parameter | Group 1 With lead in pulmonary artery ( | Group 2 (control) Without lead in pulmonary artery ( |
|
|---|---|---|---|
| Patient’s age (first implantation) | 51.6 ±18.2, 56.17, 28.75 | 57.3 ±17.4, 60.08, 19.17 | NS |
| Patient’s age (TLE) | 62.8 ±17.5, 68.0, 28.0 | 64.7 ±15.9, 68.00, 15.86 | NS |
| Gender (female) | 6 (31.6%) | 691 (39.5%) | NS |
| LRIE (isolated) | 8 (42.1%) | 189 (10.8%) | < 0.001 |
| LRIE with or without pocket infection | 9 (47.4%) | 488 (27.9%) | NS |
| Infective indications (all) | 10 (52.6%) | 709 (40.6%) | NS |
| Non-infective indications | 9 (47.4%) | 1039 (59.4%) | NS |
| Number of leads in heart before TLE | 47, 2.47 ±0.90, 2.0, 1.0 | 3507, 2.01 ±0.83, 2.0, 1.0 | < 0.05 |
| Number of leads in the system | 1.79 ±0.54, 34/47, 72.3% | 1.80 ±0.64, 3142/3507, 8.01% | NS |
| Number of abandoned leads | 0.68 ±0.82, 13/47, 72.3% | 0.21 ±0.55, 365/3507, 10.4% | < 0.001 |
| Intracardiac lead abrasion | 11 (57.9%) | 289 (16.5%) | < 0.001 |
| Number of procedures before lead extraction | 44, 2.32 ±0.20, 2.0, 2.0 | 3289, 1.88 ±1.16, 2.0, 1.0 | NS |
| ICD lead extraction | 1 (5.3%) | 450 (25.7%) | NS |
| Mean lead body dwelling time [years] | 9.46 ±5.65, 9.92, 8.50 | 6.91 ±4.99, 5.73, 6.10 | < 0.05 |
Relationship between demographic, CIED-related parameters, the reason for TLE and LDPA presence under uni- and multivariable regression analysis
| Parameter | Univariable regression | Three-variable regression model | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI |
| HR | 95% CI |
| |
| Patient’s age (first implantation) | 0.98 | 0.96–1.01 | NS | |||
| Patient’s age (TLE) | 0.99 | 0.97–1.02 | NS | |||
| Gender (female) | 1.42 | 0.54–3.75 | NS | |||
| Non-infective indications | 0.61 | 0.25–1.51 | NS | |||
| Infective indications (all) | 1.64 | 0.66–4.05 | NS | |||
| LRIE (all) | 2.32 | 0.94–5.75 | 0.068 | |||
| LRIE + pocket infection | 0.28 | 0.04–2.02 | NS | |||
| LRIE (isolated) | 6.00 | 2.38–15.1 | < 0.001 | 4.14 | 1.57–10.91 | < 0.001 |
| Pocket infection (isolated) | 0.37 | 0.05–2.85 | NS | |||
| Number of leads in heart before TLE | 1.66 | 1.11–2.49 | 0.015 | |||
| Number of leads in the system | 0.98 | 0.55–1.76 | NS | |||
| Number of abandoned leads | 2.19 | 1.39–3.46 | 0.001 | 1.85 | 1.14–3.00 | < 0.05 |
| Intracardiac lead abrasion | 4.80 | 1.92–12.0 | 0.001 | 2.90 | 1.09–7.73 | < 0.001 |
| Number of procedures before lead extraction | 1.28 | 0.95–1.73 | NS | |||
| ICD lead presence | 0.15 | 0.02–1.12 | 0.064 | 0.21 | 0.03–1.66 | NS |
| Mean lead body dwelling time | 1.09 | 1.01–1.17 | 0.024 | 1.04 | 0.97–1.12 | NS |
Variables included in three-variable regression model
Variables added individually to three-variable regression model, LRIE all – lead-related infective endocarditis all.
Assessment of TLE effects in patients with LDPA
| Patient/procedure information | With lead in pulmonary artery | Without lead in pulmonary artery |
|
|---|---|---|---|
| Full radiological success | 19 (100.0%) | 1664 (95.2%) | 0.31 |
| Clinical success | 18 (94.7%) | 1713 (98.0%) | 0.30 |
| Procedural success | 18 (94.7%) | 1663 (95.1%) | 0.94 |
| Technical problems during TLE | 6 (31.6%) | 268 (15.3%) | 0.100 |
| Major complications | 1 (5.3%) | 27 (1.5%) | 0.19 |
| Minor complications | 0 (0.0%) | 26 (1.5%) | 0.595 |
| Operating room stay-in time (whole procedure duration) [min], mean ± SD | 159.2 ±69.2 | 108.0 ±44.4 | < 0.001 |
Figure 2Survival after TLE in mean 3-year follow-up. There were no significant differences in long-term mortality between compared groups (with LDPA and without LDPA)